1. Home
  2. Medical Research
  3. Peabody, MA
  4. The Progeria Research Foundation

The Progeria Research Foundation

The Progeria Research Foundation is ranked among medical research organizations in Peabody, MA, with an America's Best Score of 83 out of 100, based on its 2025 Form 990.

  • Peabody, MA
  • Tax-exempt since 1999
  • EIN: 04-3460220
progeriaresearch.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
83OF 100 Ranked in Peabody Medical Research How this score is calculated

Organization summary

The Progeria Research Foundation is a 501(c)(3) organization, classified under Medical Research (NTEE H122). Contributions are tax-deductible.

200 Lake St Ste 102, Peabody, MA 01960-4781

In fiscal year 2025 it reported $4,458,016 in revenue and $4,163,643 in expenses, with contributions making up 45.3% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

Discover treatments & cure for progeria & its aging related disorders, including heart disease.

Largest programs · fiscal year 2025

  • Progeria drug trial: The Progeria Research Foundation and boston children's hospital continue their partnership for conducting clinical drug trials for children with progeria. The clinical trial team: A team of professionals at boston children's hospital and brigham & women's hospital working with children with progeria from around the globe. $927,130 spent · 30.7% of program spending
  • Future trial efforts: Prf engages members in the scientific community with expertise in various drugs and/or genetic therapies for the treatment and potential cure for progeria. The investigation and collaborative evaluation of drug therapies is pursued to identify drug candidates/genetic therapies that can lead to future clinical trials. $574,601 spent · 19.0% of program spending
  • Diagnostic testing: Prf developed a diagnostic test for progeria in the wake of the 2003 gene discovery so those with progeria, their families and medical caretakers can for the first time be given a definitive scientific diagnosis. This can translate into earlier diagnosis, fewer misdiagnoses and early medical intervention to ensure a better quality of life for those with progeria.(see schedule o… Read more

    Diagnostic testing: Prf developed a diagnostic test for progeria in the wake of the 2003 gene discovery so those with progeria, their families and medical caretakers can for the first time be given a definitive scientific diagnosis. This can translate into earlier diagnosis, fewer misdiagnoses and early medical intervention to ensure a better quality of life for those with progeria.(see schedule o for continuation)medical & research database: The database is a collection of medical records of progeria patients from all over the world. The data is rigorously analyzed to determine the best course of treatments to improve the patients' quality of life. This information is invaluable for the attending physician to guide the family through the best course of action. Database material was used to create prf's comprehensive healthcare recommendations handbook on progeria aimed at optimizing quality of life. The database was also critical in determining the primary clinical outcome parameter for past progeria clinical drug trials.prf translation program: In touch with the world. With a prominent global outreach, prf eliminates barriers of communication for patients and their families around the world. This initiative has succeeded in translating prf program and medical care materials into over 3 dozen different languages.the progeria handbook: A guide for families and health care providers of children and young adults with progeria that includes daily care recommendations and extensive treatment guidelines. It is published in English and several other languages to allow its use throughout the world.international progeria registry: Consists of centralized contact and other information on children and families living with progeria. The registry provides data on patient demographics and assures rapid distribution of any new information that may benefit those with progeria.scientific conferences; prf organizes meetings that bring together scientists and clinicians from all over the world to share their expertise and cutting edge scientific data, and foster collaboration in the fight against progeria and other aging related conditions.clinical trials: In 2025, 7 children and young adults came to boston to undergo testing and obtain lonafarnib for the prolon 3 (lonafarnib extension) trial, which allows children and young adults who are unable to obtain lonafarnib in their home country to receive this life extending treatment through this trial, while also gathering important disease-related data. In 2025, the team continues to gather data from the ongoing clinical drug trial. In addition, prf collaborated with prg science & technology in a trial involving the drug progerinin. Ten children and young adults came to boston three times in 2025 to participate in the trial. One of the 10 participants one also participated in the prolon 3 trial simultaneously during one of the visits.

    $1,522,985 spent · 50.4% of program spending

Where each dollar went · fiscal year 2025

Of every dollar it spent, 73¢ went to programs, 22¢ to management and 5¢ to fundraising.

  • Programs $3,024,716
  • Management $930,856
  • Fundraising $208,071

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score83 / 100
DesignationRanked

Score breakdown

MeasureThis organizationPoints
Operating reserves10+ yrs; 24.0 mo in cash25 / 25
Financial balance (median margin)−40.4%5 / 20
Transparency4 full 990s, latest TY202520 / 20
Program growth+10.0% / yr12.5 / 15
Track record27 years10 / 10
Debt load1.1% of assets10 / 10
Total82.5 → 83
Spending on programs
Not scored; America's Best needs 65%+
73%Meets

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$4,458,016Fiscal year 20252022: $1,793,85020222023: $2,231,50020232024: $3,650,30820242025: $4,458,0162025
Expenses$4,163,643Fiscal year 20252022: $3,126,76620222023: $3,929,96520232024: $5,902,36820242025: $4,163,6432025
Total assets$49,979,002Fiscal year 20252022: $47,596,73320222023: $48,844,68520232024: $48,028,50020242025: $49,979,0022025
Total liabilities$526,805Fiscal year 20252022: $772,34920222023: $593,51920232024: $627,82920242025: $526,8052025
Fiscal year ending December 2025
Revenue$4,458,016
Expenses$4,163,643
Net income$294,373
Net assets$49,452,197

Notable sources of revenue

Percent of total revenue
Contributions$2,020,617
Program services$0
Investment income$2,433,984
Other (net)$3,415

Assets / debt

Total assets$49,979,002
Total liabilities$526,805
Net assets$49,452,197

Compensation

Not in our extract for this year.

Fiscal year ending December 2024
Revenue$3,650,308
Expenses$5,902,368
Net income−$2,252,060
Net assets$47,400,671

Notable sources of revenue

Percent of total revenue
Contributions$1,862,392
Program services$0
Investment income$1,752,842
Other (net)$35,074

Assets / debt

Total assets$48,028,500
Total liabilities$627,829
Net assets$47,400,671

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$2,231,500
Expenses$3,929,965
Net income−$1,698,465
Net assets$48,251,166

Notable sources of revenue

Percent of total revenue
Contributions$1,555,410
Program services$0
Investment income$668,402
Other (net)$7,688

Assets / debt

Total assets$48,844,685
Total liabilities$593,519
Net assets$48,251,166

Compensation

Not in our extract for this year.

Fiscal year ending December 2022
Revenue$1,793,850
Expenses$3,126,766
Net income−$1,332,916
Net assets$46,824,384

Notable sources of revenue

Percent of total revenue
Contributions$2,118,542
Program services$0
Investment income$1,032,490
Other (net)−$1,357,182

Assets / debt

Total assets$47,596,733
Total liabilities$772,349
Net assets$46,824,384

Compensation

Officers and key employees$215,500
Share of expenses6.9%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?